Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Liabilities from Discontinued Operations (2018)

Ironwood Pharmaceuticals (IRWD) has disclosed Liabilities from Discontinued Operations for 1 consecutive years, with 15739000.0 as the latest value for Q4 2018.

  • Quarterly Liabilities from Discontinued Operations changed N/A to 15739000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was 15739000.0 through Dec 2018, changed N/A year-over-year, with the annual reading at 15739000.0 for FY2018, N/A changed from the prior year.
  • Liabilities from Discontinued Operations hit 15739000.0 in Q4 2018 for Ironwood Pharmaceuticals.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 15739000.0 in Q4 2018 to a low of 15739000.0 in Q4 2018.